Page last updated: 2024-08-22

uridine diphosphate glucuronic acid and dasatinib

uridine diphosphate glucuronic acid has been researched along with dasatinib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamath, AV; Lee, FY; Marathe, PH; Wang, J1

Other Studies

1 other study(ies) available for uridine diphosphate glucuronic acid and dasatinib

ArticleYear
Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:3

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Dasatinib; Dogs; Enzyme Inhibitors; Haplorhini; Hepatocytes; Humans; In Vitro Techniques; Intestinal Absorption; Macaca fascicularis; Mice; Mice, Knockout; Microsomes, Liver; NADH, NADPH Oxidoreductases; Protein Binding; Proto-Oncogene Proteins c-bcr; Pyrimidines; Rats; Species Specificity; src-Family Kinases; Thiazoles; Uridine Diphosphate Glucuronic Acid

2008